Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 07/05/2018
Entire Document
 


Case 18-10518-KG    Doc 446    Filed 06/29/18    Page 11 of 11

 

In re: Orexigen Therapeutics, Inc.    Case No. 18-10518 (KG)
Debtor    Reporting Period: May 1, 2018 - May 31, 2018

 

MOR-5

Accounts Receivable Aging

As of May 31, 2018

(Unaudited)

 

$ USD ‘000s

 

Accounts Receivable Aging

   Current      0-30 Days      31-60 Days      61-90 Days      91 Days +      Total  

Accounts Receivable, net

   $ 26,366      $ 217      $ 3,500      $ 2      $ 41      $ 30,126  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ 26,366      $ 217      $ 3,500      $ 2      $ 41      $ 30,126  

Debtor Questionnaire

 

Must be completed each month

  

Yes

  

No

1. Have any assets been sold or transferred outside the normal course of business this reporting period? If yes, provide an explanation below.

      x

2. Have any funds been disbursed from any account other than a debtor in possession account this reporting period? If yes, provide an explanation below.

      x

3. Have all post petition tax returns been timely filed? If no, provide an explanation below.

   x   

4. Are workers compensation, general liability and other necessary insurance coverages in effect? If no, provide an explanation below.

   x   

5. Has any bank account been opened during the reporting period? If yes, provide documentation identifying the opened account(s). If an investment account has been opened provide the required documentation pursuant to the Delaware Local Rule 4001-3.

      x